CN101641103B - 脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途 - Google Patents

脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途 Download PDF

Info

Publication number
CN101641103B
CN101641103B CN2008800050836A CN200880005083A CN101641103B CN 101641103 B CN101641103 B CN 101641103B CN 2008800050836 A CN2008800050836 A CN 2008800050836A CN 200880005083 A CN200880005083 A CN 200880005083A CN 101641103 B CN101641103 B CN 101641103B
Authority
CN
China
Prior art keywords
chitosan
purposes
nail
preparation
aminoglycan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008800050836A
Other languages
English (en)
Chinese (zh)
Other versions
CN101641103A (zh
Inventor
F·麦兰德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polichem SA
Original Assignee
Polichem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38212471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101641103(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem SA filed Critical Polichem SA
Publication of CN101641103A publication Critical patent/CN101641103A/zh
Application granted granted Critical
Publication of CN101641103B publication Critical patent/CN101641103B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
CN2008800050836A 2007-02-14 2008-02-07 脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途 Expired - Fee Related CN101641103B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07102338.6 2007-02-14
EP07102338A EP1958639A1 (en) 2007-02-14 2007-02-14 Use of chitosans for the treatment of nail inflammatory diseases
PCT/EP2008/051479 WO2008098871A2 (en) 2007-02-14 2008-02-07 Use of chitosans for the treatment of nail inflammatory diseases

Publications (2)

Publication Number Publication Date
CN101641103A CN101641103A (zh) 2010-02-03
CN101641103B true CN101641103B (zh) 2013-05-15

Family

ID=38212471

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008800050836A Expired - Fee Related CN101641103B (zh) 2007-02-14 2008-02-07 脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途

Country Status (30)

Country Link
US (1) US8906881B2 (enExample)
EP (3) EP1958639A1 (enExample)
JP (3) JP2010518139A (enExample)
KR (1) KR101468479B1 (enExample)
CN (1) CN101641103B (enExample)
AR (1) AR065317A1 (enExample)
AU (1) AU2008214695B2 (enExample)
BR (1) BRPI0807596A2 (enExample)
CA (1) CA2676259C (enExample)
CL (1) CL2008000443A1 (enExample)
CO (1) CO6210818A2 (enExample)
CY (1) CY1113822T1 (enExample)
DK (1) DK2117565T3 (enExample)
EA (1) EA019539B1 (enExample)
EC (1) ECSP099631A (enExample)
ES (1) ES2394169T3 (enExample)
HR (1) HRP20120915T1 (enExample)
IL (1) IL200091A (enExample)
MA (1) MA31237B1 (enExample)
ME (1) ME00828B (enExample)
MX (1) MX2009008514A (enExample)
MY (1) MY150502A (enExample)
NZ (1) NZ578937A (enExample)
PL (1) PL2117565T3 (enExample)
PT (1) PT2117565E (enExample)
RS (1) RS52620B (enExample)
SI (1) SI2117565T1 (enExample)
UA (1) UA101151C2 (enExample)
WO (1) WO2008098871A2 (enExample)
ZA (1) ZA200904975B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
EP2324838A1 (en) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions Comprising Dimethyl Sulfoxide (DMSO)
US10201490B2 (en) * 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
JP2012514644A (ja) * 2009-01-08 2012-06-28 アラーガン インコーポレイテッド 爪成長の増進用シクロスポリン組成物
AU2010313253B2 (en) 2009-10-30 2015-02-19 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EA033767B1 (ru) * 2014-06-10 2019-11-22 Makhbuba Nabi Kyzy Velieva Средство против выпадения волос на основе лекарственных растений
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
KR102511613B1 (ko) * 2019-09-23 2023-03-17 포항공과대학교 산학협력단 키토산을 포함하는 면역억제용 조성물 및 이의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1812763A (zh) * 2003-06-23 2006-08-02 波利化学公司 局部用的指甲重构组合物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (enExample) 1972-05-19 1975-08-18 Bofors Ab
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
JPH08245401A (ja) * 1995-03-14 1996-09-24 Osamu Hatanaka 皮膚保護剤
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US7147854B2 (en) * 1997-06-23 2006-12-12 Yes Biotech Laboratories Ltd. Topical treatment of psoriasis using neutralizing antibodies to interleukin-8
JP4185173B2 (ja) 1997-08-07 2008-11-26 株式会社ノエビア 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤
WO2000015202A2 (de) * 1998-09-10 2000-03-23 Ipr-Institute For Pharmaceutical Research Ag Topisch anwendbare mittel
DE19911056B9 (de) 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
JP2001055335A (ja) * 1999-08-18 2001-02-27 Toshio Sato アレルギー性皮膚疾患治療剤
JP2001131030A (ja) * 1999-11-08 2001-05-15 Kureha Chem Ind Co Ltd 発毛促進剤
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
NO310176B1 (no) 2000-11-13 2001-06-05 Wadlund As Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne
KR20020048534A (ko) 2000-12-18 2002-06-24 안병로 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제
SE0100166D0 (sv) 2001-01-22 2001-01-22 Tacton Systems Ab Configuration system
KR100457546B1 (ko) 2001-05-02 2004-11-18 주식회사 바이오프로젠 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
PT1455802E (pt) * 2001-12-14 2008-11-03 Dnp Canada Inc Oligossacáridos de quitosano e suas utilizações
KR100470753B1 (ko) * 2003-01-09 2005-03-10 주식회사 자광 수용성 천연필름과 그의 제조방법
JP2004231604A (ja) 2003-01-31 2004-08-19 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 担体シートおよび徐放性製剤ならびにそれらの製法
US20050112151A1 (en) 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
RU2258516C1 (ru) * 2004-01-20 2005-08-20 Государственное Образовательное Учреждение "Красноярская Государственная Медицинская Академия Министерства Здравоохранения Российской Федерации" Способ лечения красного плоского лишая
JP2005306746A (ja) 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
JP4804770B2 (ja) * 2005-02-28 2011-11-02 株式会社アリミノ ヘアーコンディショニング剤およびその使用方法
EP1874320A1 (en) * 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
HUE035956T2 (en) 2005-06-14 2018-05-28 Genis Hf Preparations of partially deacetylated chitin derivatives
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
EP1842545A1 (en) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1812763A (zh) * 2003-06-23 2006-08-02 波利化学公司 局部用的指甲重构组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
权利要求1，3，4，6，10-12.

Also Published As

Publication number Publication date
JP2014208709A (ja) 2014-11-06
IL200091A (en) 2013-05-30
AU2008214695A1 (en) 2008-08-21
EP1958639A1 (en) 2008-08-20
ZA200904975B (en) 2010-09-29
IL200091A0 (en) 2010-04-15
EP2117565B1 (en) 2012-10-17
JP2016188252A (ja) 2016-11-04
UA101151C2 (ru) 2013-03-11
AU2008214695B2 (en) 2013-10-03
JP6035292B2 (ja) 2016-11-30
HK1132919A1 (en) 2010-03-12
EA019539B1 (ru) 2014-04-30
US20100104670A1 (en) 2010-04-29
PT2117565E (pt) 2013-01-07
AU2008214695A2 (en) 2009-09-03
US8906881B2 (en) 2014-12-09
ES2394169T3 (es) 2013-01-23
KR20090121302A (ko) 2009-11-25
WO2008098871A2 (en) 2008-08-21
CA2676259C (en) 2015-07-14
ECSP099631A (es) 2009-12-28
NZ578937A (en) 2012-05-25
MY150502A (en) 2014-01-30
SI2117565T1 (sl) 2013-01-31
KR101468479B1 (ko) 2014-12-05
EA200901113A1 (ru) 2010-02-26
CA2676259A1 (en) 2008-08-21
CY1113822T1 (el) 2016-07-27
ME00828B (me) 2012-03-20
HRP20120915T1 (hr) 2012-12-31
EP2455086A1 (en) 2012-05-23
DK2117565T3 (da) 2012-11-19
EP2117565A2 (en) 2009-11-18
RS52620B (sr) 2013-06-28
WO2008098871A3 (en) 2008-10-09
CL2008000443A1 (es) 2008-08-22
JP2010518139A (ja) 2010-05-27
MA31237B1 (fr) 2010-03-01
MX2009008514A (es) 2009-08-20
BRPI0807596A2 (pt) 2014-07-22
CN101641103A (zh) 2010-02-03
CO6210818A2 (es) 2010-10-20
PL2117565T3 (pl) 2013-03-29
AR065317A1 (es) 2009-05-27

Similar Documents

Publication Publication Date Title
CN101641103B (zh) 脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途
Suharyani et al. Evolution of drug delivery systems for recurrent aphthous stomatitis
US6231875B1 (en) Acidified composition for topical treatment of nail and skin conditions
EP2457581B1 (en) Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis
CN101641082A (zh) 用于向皮肤释放药物的形成表膜的液体制剂
EA018390B1 (ru) Применение хитозана, аминополисахарида хитозана и/или его физиологически приемлемой соли для ускорения роста ногтей
JP2015530380A (ja) 乾癬を治療するための組成物
JP2001097848A (ja) 外用剤組成物
US10201490B2 (en) Use of chitosans for the treatment of nail inflammatory diseases
HK1169801A (en) Use of chitosans for the treatment of nail inflammatory diseases
HK1132919B (en) Use of chitosans for the treatment of nail inflammatory diseases
HK1171193B (en) Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis
AU2003246031A8 (en) An acidified composition for topical treatment of nail and skin conditions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130515

Termination date: 20210207